New cord blood treatment shows promise for tough blood cancers
NCT ID NCT03913026
First seen Nov 01, 2025 · Last updated May 23, 2026 · Updated 28 times
Summary
This study tests a special cord blood transplant (called UM171-expanded) in 30 people with high-risk leukemia or myelodysplasia. The goal is to see if this method lowers the chance of death from the transplant and helps patients live longer without the cancer coming back. Early results suggest it may be safer and more effective than standard cord blood transplants.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK HEMATOLOGIC MALIGNANCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
CIUSSS de l'Est-de-l'île-de Montreal, Hôpital Maisonneuve-Rosemont
Montreal, Quebec, H1T2M4, Canada
Conditions
Explore the condition pages connected to this study.